
Replimune Group (REPL) Financial Statements
Price: $7.49
Market Cap: $576.84M
Avg Volume: 749.55K
Market Cap: $576.84M
Avg Volume: 749.55K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Replimune Group.
Income Statement
Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 |
---|---|---|---|---|---|---|---|---|
Revenue | $- | $- | $- | $- | $- | $- | $- | $- |
Cost of Revenue | $2.65M | $2.45M | $4.58M | $4.14M | $1.81M | $148.00K | $109.00K | $122.00K |
Gross Profit | $-2.65M | $-2.45M | $-4.58M | $-4.14M | $-1.81M | $-148.00K | $-109.00K | $-122.00K |
Gross Profit Ratio | - | - | - | - | - | - | - | - |
Research and Development Expenses | $174.96M | $126.53M | $79.55M | $56.75M | $38.76M | $22.17M | $13.52M | $6.94M |
General and Administrative Expenses | $- | $- | $- | $23.20M | $17.44M | $8.77M | $5.71M | $2.71M |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $59.81M | $50.55M | $38.77M | $23.20M | $17.44M | $8.77M | $5.71M | $2.71M |
Other Expenses | $- | $-5.68M | $-1.06M | $-665.00K | $-16.00K | $451.00K | $-2.06M | $626.00K |
Operating Expenses | $234.77M | $174.17M | $115.14M | $77.15M | $53.11M | $28.42M | $16.96M | $8.21M |
Cost and Expenses | $234.77M | $174.17M | $115.14M | $77.15M | $53.11M | $28.42M | $16.96M | $8.21M |
Interest Income | $16.70M | $10.01M | $390.00K | $916.00K | $2.42M | $2.58M | $288.00K | $25.00K |
Interest Expense | $- | $4.16M | $2.22M | $3.06M | $1.92M | $- | $- | $- |
Depreciation and Amortization | $2.65M | $2.45M | $4.58M | $4.14M | $1.81M | $148.00K | $109.00K | $122.00K |
EBITDA | $-230.20M | $-170.30M | $-114.41M | $-76.48M | $-52.60M | $-28.27M | $-16.85M | $-8.08M |
EBITDA Ratio | - | - | - | - | - | - | - | - |
Operating Income | $-234.77M | $-177.08M | $-118.31M | $-79.95M | $-56.20M | $-30.95M | $-19.23M | $-9.65M |
Operating Income Ratio | - | - | - | - | - | - | - | - |
Total Other Income Expenses Net | $19.39M | $3.08M | $278.00K | $-915.00K | $3.57M | $112.00K | $-473.00K | $1.94M |
Income Before Tax | $-215.39M | $-174.00M | $-118.04M | $-80.87M | $-52.62M | $-30.83M | $-19.70M | $-7.70M |
Income Before Tax Ratio | - | - | - | - | - | - | - | - |
Income Tax Expense | $408.00K | $288.00K | $1.16M | $2.40M | $1.90M | $451.00K | $-2.06M | $125.00K |
Net Income | $-215.79M | $-174.28M | $-118.04M | $-80.87M | $-52.62M | $-30.83M | $-19.70M | $-7.70M |
Net Income Ratio | - | - | - | - | - | - | - | - |
EPS | $-3.24 | $-2.99 | $-2.26 | $-1.75 | $-1.54 | $-1.33 | $-0.64 | $-0.36 |
EPS Diluted | $-3.24 | $-2.99 | $-2.26 | $-1.75 | $-1.54 | $-1.33 | $-0.64 | $-0.25 |
Weighted Average Shares Outstanding | 66.57M | 58.21M | 52.21M | 46.25M | 34.26M | 23.20M | 30.84M | 21.51M |
Weighted Average Shares Outstanding Diluted | 66.57M | 58.21M | 52.21M | 46.25M | 34.26M | 23.20M | 30.84M | 30.84M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 |
---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $74.46M | $146.59M | $105.95M | $182.52M | $59.50M | $25.70M | $17.58M | $20.59M |
Short Term Investments | $346.21M | $436.80M | $289.71M | $293.78M | $109.06M | $109.11M | $43.97M | $- |
Cash and Short Term Investments | $420.67M | $583.39M | $395.65M | $476.30M | $168.56M | $134.81M | $61.55M | $20.59M |
Net Receivables | $4.92M | $2.94M | $3.06M | $2.95M | $2.96M | $2.47M | $2.39M | $1.41M |
Inventory | $- | $- | $- | $- | $- | $- | $- | $- |
Other Current Assets | $8.08M | $6.28M | $3.27M | $4.49M | $1.76M | $3.70M | $763.00K | $401.00K |
Total Current Assets | $433.67M | $592.60M | $403.98M | $483.75M | $174.25M | $140.98M | $64.70M | $22.40M |
Property Plant Equipment Net | $52.35M | $52.35M | $55.58M | $57.72M | $58.21M | $12.16M | $370.00K | $342.00K |
Goodwill | $- | $- | $- | $- | $- | $- | $- | $- |
Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
Long Term Investments | $- | $1.64M | $1.64M | $1.64M | $1.64M | $1.19M | $78.00K | $75.00K |
Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Assets | $1.70M | $- | $- | $- | $- | $- | $- | $- |
Total Non-Current Assets | $54.05M | $53.99M | $57.22M | $59.35M | $59.85M | $13.35M | $448.00K | $417.00K |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $487.72M | $646.59M | $461.19M | $543.10M | $234.10M | $154.33M | $65.15M | $22.82M |
Account Payables | $2.58M | $5.36M | $3.73M | $2.35M | $3.43M | $7.08M | $1.99M | $323.00K |
Short Term Debt | $3.88M | $3.76M | $7.26M | $6.91M | $6.57M | $- | $- | $- |
Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $21.71M | $12.07M | $8.22M | $4.85M | $- | $- | $- |
Other Current Liabilities | $33.98M | $24.70M | $9.76M | $5.28M | $1.87M | $2.80M | $3.17M | $1.66M |
Total Current Liabilities | $40.44M | $33.83M | $20.76M | $14.55M | $11.87M | $9.88M | $5.16M | $1.99M |
Long Term Debt | $71.99M | $57.00M | $29.21M | $29.82M | $38.51M | $- | $- | $- |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $786.00K | $472.00K | $- | $- | $- | $6.58M | $88.06M | $32.35M |
Total Non-Current Liabilities | $72.78M | $57.47M | $29.21M | $29.82M | $38.51M | $6.58M | $88.06M | $32.35M |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $113.21M | $91.30M | $49.96M | $44.37M | $50.38M | $16.47M | $93.22M | $34.33M |
Preferred Stock | $- | $- | $- | $- | $- | $- | $86.36M | $31.61M |
Common Stock | $61.00K | $57.00K | $47.00K | $47.00K | $37.00K | $32.00K | $5.00K | $5.00K |
Retained Earnings | $-701.28M | $-485.49M | $-311.20M | $-193.17M | $-112.30M | $-59.77M | $-28.93M | $-9.23M |
Accumulated Other Comprehensive Income Loss | $4.86M | $5.73M | $-973.00K | $-394.00K | $-982.00K | $-1.05M | $-238.00K | $-2.55M |
Other Total Stockholders Equity | $1.07B | $1.03B | $723.36M | $692.24M | $296.96M | $198.65M | $-86.36M | $-31.60M |
Total Stockholders Equity | $374.51M | $555.29M | $411.23M | $498.73M | $183.72M | $137.86M | $-28.07M | $-11.52M |
Total Equity | $374.51M | $555.29M | $411.23M | $498.73M | $183.72M | $137.86M | $-28.07M | $-11.52M |
Total Liabilities and Stockholders Equity | $487.72M | $646.59M | $461.19M | $543.10M | $234.10M | $154.33M | $65.15M | $22.82M |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $487.72M | $646.59M | $461.19M | $543.10M | $234.10M | $154.33M | $65.15M | $22.82M |
Total Investments | $346.21M | $436.80M | $289.71M | $293.78M | $109.06M | $109.11M | $43.97M | $75.00K |
Total Debt | $75.87M | $60.76M | $32.84M | $33.28M | $41.79M | $6.56M | $- | $- |
Net Debt | $1.41M | $-85.83M | $-73.11M | $-149.24M | $-17.71M | $-19.14M | $-17.58M | $-20.59M |
Cash Flow Statement
Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 |
---|---|---|---|---|---|---|---|---|
Net Income | $-215.79M | $-174.28M | $-118.04M | $-80.87M | $-52.62M | $-30.83M | $-19.70M | $-7.70M |
Depreciation and Amortization | $2.65M | $2.45M | $2.15M | $1.71M | $533.00K | $148.00K | $109.00K | $122.00K |
Deferred Income Tax | $- | $38.00K | $- | $2.29M | $-945.00K | $3.74M | $849.00K | $- |
Stock Based Compensation | $34.12M | $28.13M | $24.25M | $11.79M | $7.74M | $2.73M | $812.00K | $208.00K |
Change in Working Capital | $5.48M | $15.12M | $7.24M | $3.51M | $-15.41M | $-1.25M | $1.89M | $147.00K |
Accounts Receivables | $- | $-61.00K | $-247.00K | $325.00K | $-628.00K | $-255.00K | $-767.00K | $-1.21M |
Inventory | $- | $61.00K | $247.00K | $-325.00K | $628.00K | $255.00K | $- | $- |
Accounts Payables | $-2.79M | $1.98M | $1.12M | $-1.03M | $-3.82M | $120.00K | $1.60M | $203.00K |
Other Working Capital | $8.28M | $13.14M | $6.12M | $4.54M | $-11.59M | $-1.37M | $296.00K | $-56.00K |
Other Non Cash Items | $-11.94M | $494.00K | $2.22M | $181.00K | $156.00K | $93.00K | $26.00K | $150.00K |
Net Cash Provided by Operating Activities | $-185.47M | $-128.05M | $-82.18M | $-61.39M | $-60.55M | $-25.38M | $-16.01M | $-7.08M |
Investments in Property Plant and Equipment | $-5.66M | $-2.27M | $-2.34M | $-2.39M | $-6.54M | $-2.60M | $-136.00K | $-238.00K |
Acquisitions Net | $- | $140.23K | $-530 | $186.38K | $-1.31K | $- | $- | $- |
Purchases of Investments | $-489.52M | $-583.41M | $-255.72M | $-392.43M | $-149.68M | $-189.93M | $-52.46M | $- |
Sales Maturities of Investments | $592.38M | $443.18M | $256.25M | $206.05M | $150.99M | $126.59M | $8.55M | $- |
Other Investing Activities | $- | $-140.23K | $530 | $-186.38K | $1.31K | $-63.34M | $-43.91M | $- |
Net Cash Used for Investing Activities | $97.20M | $-142.50M | $-1.81M | $-188.78M | $-5.23M | $-65.94M | $-44.05M | $-238.00K |
Debt Repayment | $14.52M | $27.79M | $-264.00K | $-10.14M | $9.94M | $- | $- | $- |
Common Stock Issued | $1.76M | $187.29M | $6.86M | $286.11M | $61.88M | $103.34M | $54.75M | $15.00M |
Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $1.76M | $96.22M | $6.86M | $96.50M | $28.34M | $-1.95M | $54.75M | $15.00M |
Net Cash Used Provided by Financing Activities | $16.28M | $311.30M | $6.60M | $372.46M | $100.17M | $101.39M | $54.75M | $15.00M |
Effect of Forex Changes on Cash | $-86.00K | $-109.00K | $818.00K | $721.00K | $-135.00K | $-839.00K | $2.30M | $-1.42M |
Net Change in Cash | $-72.07M | $40.64M | $-76.57M | $123.02M | $34.25M | $9.23M | $-3.01M | $6.27M |
Cash at End of Period | $76.16M | $148.23M | $107.58M | $184.15M | $61.14M | $26.89M | $17.66M | $20.67M |
Cash at Beginning of Period | $148.23M | $107.58M | $184.15M | $61.14M | $26.89M | $17.66M | $20.67M | $14.41M |
Operating Cash Flow | $-185.47M | $-128.05M | $-82.18M | $-61.39M | $-60.55M | $-25.38M | $-16.01M | $-7.08M |
Capital Expenditure | $-5.66M | $-2.27M | $-2.34M | $-2.39M | $-6.54M | $-2.60M | $-136.00K | $-238.00K |
Free Cash Flow | $-191.13M | $-130.32M | $-84.52M | $-63.78M | $-67.09M | $-27.98M | $-16.15M | $-7.32M |